Group One Trading
QTTB icon

Group One Trading’s Q32 Bio QTTB Stock Holding History

Group One Trading’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$218 Hold
34
– – ﹤0.01% 7391
2025
Q4 		$113 Hold
34
– – ﹤0.01% 7911
2025
Q3 		$67 Buy
+34
New +$65 ﹤0.01% 8257
2025
Q1 		– Sell
-3,900
Closed -$10.5K – 8502
2024
Q4 		$13.4K Buy
+3,900
New +$123K ﹤0.01% 5941
2022
Q3 		– Sell
-5,481
Closed -$224K – 8371
2022
Q2 		$194K Buy
5,481
+2,121
+63% +$72.4K ﹤0.01% 4343
2022
Q1 		$184K Buy
3,360
+2,207
+191% +$137K ﹤0.01% 4881
2021
Q4 		$76K Sell
1,153
-162
-12% -$15.7K ﹤0.01% 5973
2021
Q3 		$186K Buy
1,315
+768
+140% +$97.8K ﹤0.01% 5253
2021
Q2 		$72K Buy
+547
New +$68.3K ﹤0.01% 6268
2021
Q1 		– Sell
-39
Closed -$8.21K – 8104
2020
Q4 		$8K Sell
39
-193
-83% -$37.3K ﹤0.01% 5884
2020
Q3 		$45K Buy
+232
New +$52K ﹤0.01% 4705
2020
Q2 		– Sell
-282
Closed -$75.2K – 6260
2020
Q1 		$79K Buy
282
+137
+94% +$42K ﹤0.01% 3455
2019
Q4 		$54K Buy
+145
New +$41.5K ﹤0.01% 3976

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Group One Trading's QTTB Position: Q1 2026 in Review

Group One Trading held its Q32 Bio (QTTB) position steady in Q1 2026 at 34 shares worth $218. The position accounts for ﹤0.01% of the portfolio, ranked #7391.

Group One Trading first reported a position in QTTB in Q4 2019 and has held it in 13 quarters since. The position peaked at $194K in Q2 2022. 54 funds tracked by Wall St. Rank hold QTTB as of Q1 2026.

  • Group One Trading held 34 shares of Q32 Bio worth $218 as of Q1 2026.
  • Group One Trading left its Q32 Bio share count unchanged in Q1 2026.
  • Q32 Bio made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7391 holding.
  • Group One Trading first reported a position in Q32 Bio in Q4 2019 and has held it in 13 quarters since.
  • Group One Trading's Q32 Bio position peaked at $194K in Q2 2022.
  • 54 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.